Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Genomic Markers for Measuring Breast Cancer Response to Neoadjuvant Chemotherapy

NCT03709134 is registered in ClinicalTrials.gov with Sunnybrook Health Sciences Centre as lead sponsor.

NCT NCT03709134
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03709134 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Genomic Markers for Measuring Breast Cancer Response to Neoadjuvant Chemotherapy
Lead sponsor
Sunnybrook Health Sciences Centre
Phase
Observational
Overall status
Completed
Start date
October 1, 2019
Completion date
September 1, 2022
Enrollment
100 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

breast cancer, breast neoplasms, cancer, breast